JP Morgan Chase
ONEM

JP Morgan Chase’s 1Life Healthcare ONEM Stock Holding History

JP Morgan Chase’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-843,209
Closed -$14.1M – 7496
2022
Q4 		$14.1M Sell
843,209
-683,494
-45% -$11.5M ﹤0.01% 1937
2022
Q3 		$26.2M Buy
1,526,703
+1,363,992
+838% +$21.4M ﹤0.01% 1399
2022
Q2 		$1.28M Sell
162,711
-318,698
-66% -$2.74M ﹤0.01% 3901
2022
Q1 		$5.33M Buy
481,409
+14,669
+3% +$164K ﹤0.01% 2956
2021
Q4 		$8.2M Buy
466,740
+231,497
+98% +$4.49M ﹤0.01% 2627
2021
Q3 		$4.76M Buy
235,243
+138,702
+144% +$3.57M ﹤0.01% 3064
2021
Q2 		$3.19M Sell
96,541
-826,991
-90% -$31.2M ﹤0.01% 3428
2021
Q1 		$36.1M Buy
923,532
+852,927
+1,208% +$40M ﹤0.01% 1320
2020
Q4 		$3.08M Buy
70,605
+9,974
+16% +$341K ﹤0.01% 3178
2020
Q3 		$1.73M Buy
60,631
+34,788
+135% +$1.1M ﹤0.01% 3332
2020
Q2 		$939K Sell
25,843
-6,932
-21% -$195K ﹤0.01% 3556
2020
Q1 		$595K Buy
+32,775
New +$719K ﹤0.01% 3735

JP Morgan Chase's ONEM Position: Q1 2023 in Review

JP Morgan Chase sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 843,209 shares — an estimated $14.1M sold.

JP Morgan Chase first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $36.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • JP Morgan Chase reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 843,209 1Life Healthcare shares in Q1 2023, an estimated $14.1M.
  • JP Morgan Chase first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • JP Morgan Chase's 1Life Healthcare position peaked at $36.1M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.